Exploration of the pre-analytical stability of β-lactam antibiotics in plasma and blood - Implications for therapeutic drug monitoring and pharmacokinetic studies

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 9, 2015, Pages e227-e230

  Carlier, Mieke ^a   De Waele, Jan J ^a   Verstraete, Alain G ^a,b   Stove, Veronique ^a,b  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

carbapenem; gel adsorption; penicillin; pre analytics; lactam

Indexed keywords

AMOXICILLIN; MEROPENEM; PIPERACILLIN; ANTIINFECTIVE AGENT; BETA LACTAM;

BLOOD COLLECTION TUBE; CENTRIFUGATION; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG STABILITY; DRUG STORAGE; FREEZE THAWING; HUMAN; INTENSIVE CARE UNIT; LETTER; PRIORITY JOURNAL; STORAGE; SUPERNATANT; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UNIVERSITY HOSPITAL; BLOOD; CHEMISTRY; PLASMA;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; DRUG MONITORING; DRUG STABILITY; HUMANS; PLASMA;

EID: 84938497003     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0833     Document Type: Letter

References (11)

1. Vincent J-L, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. J Am Med Assoc 2009;302:2323-9.
2. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998;244:379-86.
3. Roberts J, Paul S, Akova M, Bassetti M, De Waele J, Dimopoulos G, et al. DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients. Clin Infect Dis 2014;58:1072-83.
4. Roberts J, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009;37:840-51.
5. Roberts JA, Ulldemolins M, Roberts MS, McWhinney B, Ungerer J, Paterson DL, et al. Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept. Int J Antimicrob Agents 2010;36:332-9.
6. De Waele JJ, Carrette S, Carlier M, Stove V, Boelens J, Claeys G, et al. Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial. Intens Care Med 2014;40:380-7.
7. Verdier MC, Tribut O, Tattevin P, Le Tulzo Y, Michelet C, Bentue-Ferrer D. Simultaneous determination of 12 beta-lactam antibiotics in human plasma by high-performance liquid chromatography with UV detection: application to therapeutic drug monitoring. Antimicrob Agents Chemother 2011;55:4873-9.
8. Beumier M, Casu GS, Hites M, Seyler L, Cotton F, Vincent J-L, et al. Beta-lactam antibiotic concentrations during continuous renal replacement therapy. Crit Care 2014;18:R105.
9. Doh K, Woo H, Hur J, Yim H, Kim J, Chae H, et al. Population pharmacokinetics of meropenem in burn patients. J Antimicrob Chemother 2010;65:2428-35.
10. Forgue ST, Pittman KA, Barbhaiya RH. High-performance liquid chromatographic analysis of a novel carbapenem antibiotic in human plasma and urine. J Chromatogr 1987;414:343-53.
11. Carlier M, Stove V, Roberts JA, Van de Velde E, De Waele JJ, Verstraete AG. Quantification of seven -lactam antibiotics and two -lactamase inhibitors in human plasma using a validated UPLC-MS/MS method. Int J Antimicrob Agents 2012;40:416-22.